Ting Bao, M.D., M.S., F.S.I.O.

(877) 460-4673
Ting Bao, M.D., M.S., F.S.I.O.
Integrative Oncologist
Clinical Expertise

Intergrative Oncology

Supportive Care

 

Academic Appointments

Professor, Departments of Supportive Care Medicine and Medical Oncology
Deputy Director, Director of Research, Cherng Family Center for Integrative Oncology

Ting Bao, M.D., M.S., F.S.I.O., is deputy director and director of research for the Cherng Family Center for Integrative Oncology at City of Hope® Cancer Center Duarte, where she also serves as professor of supportive care medicine and medical oncology.

In her role at the Cherng Center, Dr. Bao works closely with researchers and clinicians to investigate new ways to incorporate evidence-based integrative therapies into the standard-of-care for cancer patients at City of Hope and beyond. An internationally recognized scholar, Dr. Bao has published articles in more than 60 peer-reviewed journals, led numerous presentations and workshops around the world and served as principal investigator on multiple trials in the field of integrative oncology. She believes in a compassionate, whole-person approach to care that blends the best of Eastern and Western medicine.

After earning her medical degree at Johns Hopkins School of Medicine in Baltimore, Dr. Bao completed an internal medicine residency at the institute’s Bayview Medical Center and a medical oncology clinical fellowship at its Sidney Kimmel Comprehensive Cancer Center. She also holds a master’s degree from the University of Maryland and trained in medical acupuncture at the Helms Medical Institute in Berkeley, California.

Prior to joining City of Hope, Dr. Bao held an academic appointment at Harvard Medical School and was the co-director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living at Dana Farber Cancer Institute. She has also served in roles at Memorial Sloan Kettering Cancer center, Weill Cornell Medical College and Brigham and Women’s Hospital.

Location

Education & Experience

Education

  • 2013, Master of Science, Clinical Research, University of Maryland, Baltimore, MD
  • 2003, Doctor of Medicine, Johns Hopkins School of Medicine, Baltimore, MD

Residency

  • 2006, Internal Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD

Fellowship

  • 2009, Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Professional Experience

  • 2026-present, Professor, Departments of Supportive Care Medicine and Medical Oncology, City of Hope, Duarte/Irvine, CA
  • 2026-present, Deputy Director, Director of Research, Cherng Family Center for Integrative Oncology, City of Hope, Duarte/Irvine, CA
  • 2024-2026, Associate Physician, Medical Oncology, Brigham and Women’s Hospital, Boston, MA
  • 2023-2026, Physician, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • 2023-2026, Member of the Faculty, Medicine, Harvard Medical School, Boston, MA
  • 2021-2023, Associate Member, Integrative Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, New York, NY
  • 2021-2023, Associate Professor, Medicine, Weill Cornell Medical College, New York, NY

Awards & Memberships

2024, Fellow Award, Society for Integrative Oncology (SIO)

2017, People’s Choice Award, Quality Improvement Fair, MSKCC

2009, Merit Award, ASCO

Publications

  • Yang M, Zhong L, Fok RWY, Tjioe YY, Teo BS, Zhang F, Bao T. Effects and safety of traditional Chinese medicine approaches in cancer symptom care: A systematic review of phase 3 randomized clinical trials. Cancer. 2025 Nov 15;131(22):e70170. doi: 10.1002/cncr.70170. PMID: 41217297.
  • Chan A, Nasr R, Arcos D, Kagramanov D, Asuzu C, Bao T, Cheung YT, Kwon JH, Lacey J, Lee RT, Lustberg M, Ohaeri BM, Rao S, Soto-Perez-de-Celis E, Witt CM, Lopez AM. Evaluation of integrative oncology modalities for symptom management: a MASCC/SIO global survey. BMC Complement Med Ther. 2025 Nov 3;25(1):406. doi: 10.1186/s12906-025-05157-6. PMID: 41184943; PMCID: PMC12581493.
  • Martyniuk I, Kennedy V, Rose J, Bombacie M, Berman T, Bao T. How to build a thriving integrative oncology programme. BMJ Support Palliat Care. 2025 Oct 27;15(6):753-759. doi: 10.1136/spcare-2025-005620. PMID: 40983495.
  • Kwag E, Joo H, Kim SD, Park SJ, Cho JH, Lee NH, Joo JC, Hyun MH, Chimonas S, Bao T, Mao JJ, Lee JY, Yoo H. Utilization Pattern of Acupuncture and Its Associated Predictors for Cancer Pain in South Korea: A Cross-Sectional Study. Diseases. 2025 Sep 2;13(9):292. doi: 10.3390/diseases13090292. PMID: 41002728; PMCID: PMC12468660.
  • Shainhouse J, Hwang PSY, Fontes M, Bao T. Integrative medicine in breast cancer survivorship care. Ann Palliat Med. 2025 May;14(3):283-294. doi: 10.21037/apm-24-176. PMID: 40511571.
  • Im EO, Chee W, Paul S, Kim SY, Choi MY, Deatrick J, Inouye J, Ma G, Mao J, Meghani S, Nguyen GT, Schapira M, Ulrich C, Yeo SA, Bao T, Shin D. A Technology-Based Educational Intervention and Multiple Domains of Symptom Experience: Asian American Breast Cancer Survivors. J Cancer Educ. 2026 Apr;41(2):230-242. doi: 10.1007/s13187-025-02648-5. Epub 2025 May 15. PMID: 40372611; PMCID: PMC12354248.
  • Im EO, Chee W, Paul S, Kim SY, Choi MY, Mao JJ, Nguyen GT, Schapira MM, Ulrich CM, Yeo S, Deatrick JA, Inouye J, Ma G, Meghani S, Shin D, Bao T. Multiple dimensions of the quality of life among Asian American breast cancer survivors: The impact of a technology-based program. Breast. 2025 Aug;82:104490. doi: 10.1016/j.breast.2025.104490. Epub 2025 May 8. PMID: 40359896; PMCID: PMC12139231.
  • Yang M, Shao C, Shao C, Saint K, Gupta M, Caputo R, Galantino ML, Harte S, Bao T. A Retrospective Cohort Study on the Preliminary Efficacy of Massage Therapy for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients. Integr Cancer Ther. 2025 Jan-Dec;24:15347354251323258. doi: 10.1177/15347354251323258. PMID: 39995182; PMCID: PMC11863244.
  • Yang M, Shao C, Shao C, Saint K, Wayne PM, Bao T. Tai Chi for balance and postural control in people with peripheral neuropathy: A scoping review. Complement Ther Med. 2024 Nov;86:103089. doi: 10.1016/j.ctim.2024.103089. Epub 2024 Sep 24. PMID: 39326640.
  • Lu W, Giobbie‑Hurder A, Tanasijevic A, Kassis SB, Park SH, Jeong YJ, Shin IH, Yao C, Jung HJ, Zhu Z, Bao C, Bao T, Yang E, Bierer BE, Ligibel JA. Acupuncture for hot flashes in hormone receptor-positive breast cancer: a pooled analysis of individual patient data from parallel randomized trials. Cancer. 2024; 130(18):3219–3228.
  • Bao T, Lopez G, Crudup T, Lopez AM, Paller CJ, Gowin K, Mehta A, Witt CM, Zick SM, Balneaves LG. Advancing integrative oncology: the Society for Integrative Oncology Education Committee’s journey and vision. Journal of Integrative and Complementary Medicine. 2024.
  • Saint K, Paul T, Patterson C, Yang M, Bao T, Galantino ML. Assessing fidelity in yoga interventions for chemotherapy-induced peripheral neuropathy: decision-making to enhance protocol quality adherence. Integrative Cancer Therapies. 2024; 23.
  • Saint K, Nemirovsky D, Lessing A, Chen Y, Yang M, Underwood WP, Galantino ML, Jones LW, Bao T. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer. Breast Cancer Research and Treatment. 2024; 206(3):667–675.
  • Im EO, Chee W, Paul S, Choi MY, Kim SY, Yeo S, Ulrich CM, Schapira MM, Nguyen GT, Meghani S, Mao JJ, Ma G, Inouye J, Deatrick JA, Shin D, Bao T. Five dimensions of needs for help: the efficacy of a technology-based intervention among Asian American breast cancer survivors. Journal of Cancer Education. 2024; 39(3):335–348.
  • Bao T, Zhi WI, Baser RE, Li QS, Weitzman M, Gillespie EF, Robson M, Mao JJ. Electroacupuncture versus battlefield auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: subgroup analysis of a randomized clinical trial. Breast Cancer Research and Treatment. 2023; 202(2):287–295.

For a full list of publications click here.